Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New app aims to decode bowel troubles after rectal cancer

NCT ID NCT06274190

First seen Jan 20, 2026 · Last updated Jun 23, 2026 · Updated 27 times

Summary

This study is testing a smartphone app that helps rectal cancer patients track their bowel symptoms after treatment. The goal is to create a better way to diagnose and manage these symptoms, which can be long-lasting. About 158 participants will use the app for a week and give feedback on its usability and accuracy.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RECTAL CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • UZ Leuven

    RECRUITING

    Leuven, Vlaams-Brabant, 3000, Belgium

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

bowel e-diary (smartphone app)

What this could lead to

If successful, this app could give doctors a better tool to diagnose and manage bowel problems after rectal cancer treatment, improving quality of life.

What could go wrong

This is an early-stage study focused on developing and testing the app, not on treatment. It may not lead to immediate changes in care, and the app might not be easy for all patients to use.

Conditions

The condition(s) this trial relates to.

Low Anterior Resection Syndrome rectal neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.